is metformin a glp-1 receptor agonist Synergistic effects of with liraglutide against endothelial dysfunction through and PKA signalling pathway Comparing cardiovascular benefits between GLP-1

The pharmaceutical industry continues investing heavily into next-generation obesity therapies capable of improving efficacy and patient experience

While opinions vary, patterns emerge over time, helping prospective players set realistic expectations

Poor blood sugar regulation may play a role

J.GrandtD.GoebellH

Maternal body mass index and pregnancy outcomes: a systematic review and metaanalysis

From various observation studies, it has been demonstrated that the combination of different treatment methods may have an additional benefit for the patient with NAFLD/NASH compared to individual treatments alone, but further studies should be conducted in that direction